Augmentation of Blood Platelet Levels by Intratracheal Administration of an Adenovirus Vector Encoding Human Thrombopoietin cDNA

Nature Biotechnology

Volumn 15, Issue 6, 1997, Pages 570-573

  Cannizzo, Salvatore J ^a   Frey, Beat M ^a,b   Raffi, Shahin ^a   Moore, Malcolm A S ^a,b   Eaton, Dan ^c   Suzuki, Motoyoshi ^a   Singh, Ravi ^a   Mack, Charles A ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c GENENTECH INC   (United States)

Author keywords

Adenovirus; Gene therapy; Lung epithelium; Thrombopoietin

Indexed keywords

COMPLEMENTARY DNA; THROMBOPOIETIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE COUNT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BONE MARROW CELLS; CELL LINE; CYTOMEGALOVIRUS; DNA, COMPLEMENTARY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; MICE; MICE, INBRED BALB C; MUTAGENESIS, INSERTIONAL; PLATELET COUNT; RECOMBINANT PROTEINS; SPLEEN; THROMBOPOIETIN;

ADENOVIRIDAE; ANIMALIA;

EID: 0030963223     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0697-570     Document Type: Article

References (31)

1. Kaushansky, K. and Karplus, P.A. 1993. Hematopoietic growth factors: understanding functional diversity in structural terms. Blood 82:3229-3240.
2. Whetton, A.D. and Dexter, T.M. 1993. Influence of growth factors and substrates on differentiation of haemopoietic stem cells. Curr. Opin. Cell Biol. 5:1044-1049.
3. Appelbaum, F.R. 1995. Allogeneic marrow transplantation and the use of hematopoietic growth factors. Stem Cells (Dayt.) 13:344-350.
4. Neidhart, J.A. 1993. Hematopoietic cytokines. Current use in cancer therapy. Cancer 72:3381-3386.
5. Descamps, V., Blumenfeld, N., Villeval, J.L., Vainchenker, W., Perricaudet, M., and Beuzard, Y. 1994. Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. Hum. Gene Ther. 5:979-985.
6. Setoguchi, Y., Danel, C., and Crystal, R.G. 1994. Stimulation of erythropoiesis by in vivo gene therapy: physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vecto. Blood 84:2946-2953.
7. Tripathy, S.K., Black, H.B., Goldwasser, E., and Leiden, J.M. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
8. Tripathy, S.K., Goldwasser, E., Lu, M.M., Barr, E., and Leiden, J.M. 1994. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91:11557-11561.
9. Xing, Z., Braciak, T., Ohkawara, Y., Sallenave, J.M., Foley, R., Sime, P.J., et al. 1996. Gene transfer for cytokine functional studies in the lung: the multifunctional role of gm-csf in pulmonary inflammation. J. Leukoc. Biol. 59:481-488.
10. Ohwada, A., Rafii, S., Moore, M.A., and Crystal, R.G. 1996. In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation- and chemotherapy-induced bone marrow suppression. Blood 88:778-784.
11. Xing, Z., Ohkawara, Y., Jordana, M., Graham, F., and Gauldie, J. 1996. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97:1102-1110
12. Siegfried, W., Rosenfeld, M., Stier, L., Stratford-Perricaudet, L., Perricaudet, M., Pavirani, A., et al. 1995. Polarity of secretion of alpha 1-antitrypsin by human respiratory epithelial cells after adenoviral transfer of a human α1-antitrypsin cDNA. Am. J. Respir. Cell. Mol. Biol. 12:379-384.
13. Crystal, R.G., McElvaney, N.G., Rosenfeld, M.A., Chu, C.S., Mastrangeli, A., Hay, J.G., et al. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8:42-51.
14. Mastrangeli, A., Danel, O., Rosenfeld, M.A., Stratford-Perricaudet, L., Perricaudet, M., Pavirani, A., et al. 1993. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91:225-234.
15. Rosenfeld, M.A., Yoshimura, K., Trapnell, B.C., Yoneyama, K., Rosenthal, E.R., Dalemans, W., et al. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
16. Rosenfeld, M.A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L.E., et al. 1991. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252:431-434.
17. Engelhardt, J.F., Simon, R.H., Yang, Y., Zepeda, M., Weber-Pendleton, S., Doranz, B., et al. 1993. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:759-769.
18. Zabner, J., Petersen, D.M., Puga, A.P., Graham, S.M., Couture, L.A., Keyes, L.D., et al. 1994. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat. Genet. 6:75-83.
19. Bout, A., Perricaudet, M., Baskin, G., Imler, J.L., Scholte, B.J., Pavirani, A., et al. 1994. Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum. Gene Ther. 5:3-10.
20. Yei, S., Mittereder, N., Wert, S., Whitsett, J.A., Wilmott, R.W., and Trapnell, B.C. 1994. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cdna to the lung. Hum. Gene Ther. 5:731-744.
21. Crystal, R.G., Mastrangeli, A., Sanders, A., Cooke, J., King, T., Gilbert, F., et al. 1994. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis. RAC Report 9409-085.
22. Crystal, R.G., Jaffe, A., Brody, S., Mastrangeli, A., McElvaney, N.G., Rosenfeld, M., et al. 1992. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung. RAC Report 9212-034.
23. Broudy, V.C. and Kaushansky, K. 1995. Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production. J. Leukoc. Biol. 57:719-725.
24. Kaushansky, K. 1995. Thrombopoietin: the primary regulator of platelet production. Blood 86:419-431.
25. Chandra, T., Miller, I.F., and Yeates, D.B. 1992. A pore transport model for pulmonary alveolar epithelium. Ann. Biomed. Eng. 20:481-494.
26. Effros, R.M. 1997. Permeability of the blood-gas barrier, pp. 1567-1580 in The lung: scientific foundations. Crystal, R.G., West, J.B., Weibel, E.R., and Barnes, P.J. (eds). Lippincott-Raven Publishers, Philadelphia, PA.
27. Parker, J.C., Rippe, B., and Taylor, A.E. 1986. Fluid filtration and protein clearances through large and small pore populations in dog lung capillaries. Microvasc. Res. 31:1-17.
28. Rippe, B. and Crone, C. 1991. Pores and intercellular junctions, pp. 349-357 in The lung: scientific foundations. Crystal, R.G., West, J.B., Barnes, P.J., Cherniack, N.S., and Weibel, E.R. (eds). Raven Press, New York.
29. Hersh, J., Crystal, R.G., and Bewig, B. 1995. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Therapy 2:124-131.
30. de Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., et al. 1994. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature 369:533-538.
31. Frey, B.M., Cannizzo, S., Crystal, R.G., and Moore, M.A.S. 1996. Expression of human thrombopoietin transgene delivered by an adenovirus based strategy is dependent on host immune competence. Exp. Hematol. 24:1056.